149 related articles for article (PubMed ID: 29195619)
1. PET/CT in Radiation Therapy Planning.
Specht L; Berthelsen AK
Semin Nucl Med; 2018 Jan; 48(1):67-75. PubMed ID: 29195619
[TBL] [Abstract][Full Text] [Related]
2. The optimal use of PET/CT in the management of lymphoma patients.
Milgrom SA; Rechner L; Berthelsen A
Br J Radiol; 2021 Nov; 94(1127):20210470. PubMed ID: 34415777
[No Abstract] [Full Text] [Related]
3. Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications.
McKay MJ; Taubman KL; Foroudi F; Lee ST; Scott AM
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):783-791. PubMed ID: 30353883
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position.
Bird D; Patel C; Scarsbrook AF; Cosgrove V; Thomas E; Gilson D; Prestwich RJD
Radiother Oncol; 2017 Jul; 124(1):161-167. PubMed ID: 28600083
[TBL] [Abstract][Full Text] [Related]
5. Harnessing benefit of highly conformal RT techniques for lymphoma patients.
Petersen PM; Mikhaeel NG; Ricardi U; Brady JL
Br J Radiol; 2021 Nov; 94(1127):20210469. PubMed ID: 34379521
[TBL] [Abstract][Full Text] [Related]
6. Use of
Davidson T; Ben-David M; Galper S; Haskin T; Howes M; Scaife R; Kanana N; Amit U; Weizman N; Chikman B; Goshen E; Ben-Haim S; Symon Z; Goldstein J
Pract Radiat Oncol; 2017; 7(6):373-381. PubMed ID: 28989000
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy planning for the lymphomas: expanding roles for biologic imaging.
Hoppe R
Front Radiat Ther Oncol; 2011; 43():331-343. PubMed ID: 21625161
[TBL] [Abstract][Full Text] [Related]
8. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
9. The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer.
Mac Manus MP; Hicks RJ
Semin Nucl Med; 2012 Sep; 42(5):308-19. PubMed ID: 22840596
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of integrated positron emission tomography/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced rectal cancer.
Whaley JT; Fernandes AT; Sackmann R; Plastaras JP; Teo BK; Grover S; Perini RF; Metz JM; Pryma DA; Apisarnthanarax S
Pract Radiat Oncol; 2014; 4(4):226-32. PubMed ID: 25012830
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2.
Fiorentino A; Laudicella R; Ciurlia E; Annunziata S; Lancellotta V; Mapelli P; Tuscano C; Caobelli F; Evangelista L; Marino L; Quartuccio N; Fiore M; Borghetti P; Chiaravalloti A; Ricci M; Desideri I; Alongi P;
Crit Rev Oncol Hematol; 2019 Jul; 139():117-124. PubMed ID: 30940428
[TBL] [Abstract][Full Text] [Related]
12. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
13. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
14. The role of motion management and position verification in lymphoma radiotherapy.
Aznar M; Ntentas G; Enmark M; Flampouri S; Meidhal Petersen P; Ricardi U; Levis M
Br J Radiol; 2021 Nov; 94(1127):20210618. PubMed ID: 34677090
[TBL] [Abstract][Full Text] [Related]
15. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
16. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
[TBL] [Abstract][Full Text] [Related]
17. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
18. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Image Fusion of
Yu Y; Zhang WB; Liu XJ; Guo CB; Yu GY; Peng X
J Oral Maxillofac Surg; 2017 Jun; 75(6):1301.e1-1301.e15. PubMed ID: 28320612
[TBL] [Abstract][Full Text] [Related]
20. Technical aspects of positron emission tomography/computed tomography in radiotherapy treatment planning.
Scripes PG; Yaparpalvi R
Semin Nucl Med; 2012 Sep; 42(5):283-8. PubMed ID: 22840594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
